
| Pair Name | Neferine, Vitamin D3 | ||
| Phytochemical Name | Neferine (PubChem CID: 159654 ) | ||
| Anticancer drug Name | Vitamin D3 (PubChem CID: 5280795 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Neferine, Vitamin D3 | |||
| Disease Info | [ICD-11: 2B91.Z] | Colorectal cancer | Investigative | |
| Biological Phenomena | Inhibition-->Cell metastasis | |||
| Gene Regulation | Up-regulation | Expression | CDH1 | hsa999 |
| Down-regulation | Expression | CDH2 | hsa1000 | |
| Down-regulation | Expression | VIM | hsa7431 | |
| Down-regulation | Expression | SNAI1 | hsa6615 | |
| Down-regulation | Expression | SNAI2 | hsa6591 | |
| In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
| Result | These data suggest that neferine enhances the anticancer capability of VD3 and reduces the dose dependency of VD3. The combination of vitamin D with neferine appears to be a potential therapeutic strategy for CRC. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Combined effects of vitamin D and neferine on the progression and metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2023 Aug;149(9):6203-6210. doi: 10.1007/s00432-022-04552-7. | Click |